當前位置：首頁 SCI期刊 SCIE期刊工程技術(shù) 中科院3區(qū) JCRQ1 期刊介紹(非官網(wǎng))

Frontiers In Bioengineering And BiotechnologySCIE

國際簡稱：FRONT BIOENG BIOTECH 參考譯名：生物工程和生物技術(shù)前沿

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q1

基本信息：: ISSN：2296-4185; E-ISSN：2296-4185; 是否OA：開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區(qū)：Switzerland; 出版商：Frontiers Media S.A.; 出版語言：English; 出版周期：-; 出版年份：2013; 研究方向：Chemical Engineering-Bioengineering

評價信息：: 影響因子：4.3; CiteScore指數(shù)：8.3; SJR指數(shù)：0.893; SNIP指數(shù)：1.011

發(fā)文數(shù)據(jù)：: Gold OA文章占比：99.42%; 研究類文章占比：76.91%; 年發(fā)文量：1559; 自引率：0.0701...; 開源占比：0.9915; 出版撤稿占比：0; 出版國人文章占比：0.19; OA被引用占比：1

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Frontiers In Bioengineering And Biotechnology期刊介紹

The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.

In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.

期刊簡介Frontiers In Bioengineering And Biotechnology期刊介紹

《Frontiers In Bioengineering And Biotechnology》自2013出版以來，是一本工程技術(shù)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學研究結(jié)果，并為工程技術(shù)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進工程技術(shù)領(lǐng)域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道工程技術(shù)領(lǐng)域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關(guān)注點：

預計審稿時間： 12 Weeks
工程技術(shù)
MULTIDISCIPLINARY SCIENCES
SCIE
中科院3區(qū)
非預警

Cite Score數(shù)據(jù)（2024年最新版）Frontiers In Bioengineering And Biotechnology Cite Score數(shù)據(jù)

CiteScore：8.3
SJR：0.893
SNIP：1.011

學科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Histology	Q1	8 / 62	87%
大類：Medicine 小類：Biomedical Engineering	Q1	63 / 303	79%
大類：Medicine 小類：Biotechnology	Q1	65 / 311	79%
大類：Medicine 小類：Bioengineering	Q1	39 / 162	76%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Frontiers In Bioengineering And Biotechnology 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區(qū)	小類學科	分區(qū)
工程技術(shù)	3區(qū)	MULTIDISCIPLINARY SCIENCES 綜合性期刊	3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學計量學方法對國際、國內(nèi)學術(shù)期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Frontiers In Bioengineering And Biotechnology JCR分區(qū)

2023-2024 年最新版

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q1	41 / 174	76.7%
學科：ENGINEERING, BIOMEDICAL	SCIE	Q2	39 / 122	68.4%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q2	56 / 174	68.1%
學科：ENGINEERING, BIOMEDICAL	SCIE	Q2	41 / 122	66.8%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學術(shù)文獻質(zhì)量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
CHINA MAINLAND605
USA446
GERMANY (FED REP GER)242
Italy203
England161
Switzerland100
France83
Netherlands79
Spain77
Australia76

本刊中國學者近年發(fā)表論文

1、Glutamine coated titanium for synergistic sonodynamic and photothermal on tumor therapy upon targeted delivery
Author: Zhang, Lina; Zhu, Pengfeng; Wan, Ting; Wang, Huaiyan; Mao, Zhilei

Journal: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. 2023; Vol. 11, Issue , pp. -. DOI: 10.3389/fbioe.2023.1139426
2、A small-diameter vascular graft immobilized peptides for capturing endothelial colony-forming cells
Author: Tang, Yaqi; Yin, Lu; Gao, Shuai; Long, Xiaojing; Du, Zhanhui; Zhou, Yingchao; Zhao, Shuiyan; Cao, Yue; Pan, Silin

Journal: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. 2023; Vol. 11, Issue , pp. -. DOI: 10.3389/fbioe.2023.1154986
3、Glucose determination in human serum by applying inner filter effect quenching mechanism of upconversion nanoparticles
Author: Chen, Xiaojiao; Yang, Zhiying; Chen, Qiong; Zhang, Youyu

Journal: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. 2023; Vol. 11, Issue , pp. -. DOI: 10.3389/fbioe.2023.1168086
4、Current development of stretchable self-powered technology based on nanomaterials toward wearable biosensors in biomedical applications
Author: Wang, Qianqian; Sun, Xu; Liu, Chen; Wang, Chunge; Zhao, Wenjie; Zhu, Zehui; Ma, Sainan; Zhang, Sheng

Journal: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. 2023; Vol. 11, Issue , pp. -. DOI: 10.3389/fbioe.2023.1164805
5、Three-dimensional core-shell alginate microsphere for cancer hypoxia simulation in vitro
Author: Ruan, Yejiao; He, Lingyun; Chen, Jiamin; Wang, Jinfeng; Zhao, Shujing; Guo, Xiaoling; Xie, Yao; Cai, Zhenzhai; Shen, Xian; Li, Chao

Journal: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. 2023; Vol. 11, Issue , pp. -. DOI: 10.3389/fbioe.2023.1174206
6、Research progress on albumin-based hydrogels: Properties, preparation methods, types and its application for antitumor-drug delivery and tissue engineering
Author: Meng, Run; Zhu, Huimin; Deng, Peiying; Li, Minghui; Ji, Qingzhi; He, Hao; Jin, Liang; Wang, Bochu

Journal: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. 2023; Vol. 11, Issue , pp. -. DOI: 10.3389/fbioe.2023.1137145
7、Comparison of proteomic landscape of extracellular vesicles in pleural effusions isolated by three strategies
Author: Yao, Xue; Liao, Baixue; Chen, Feng; Liu, Lueye; Wu, Kaiwen; Hao, Yaying; Li, Yanping; Wang, Yuebin; Fan, Ruiling; Yin, Jun; Liu, Lei; Guo, Yuanbiao

Journal: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. 2023; Vol. 11, Issue , pp. -. DOI: 10.3389/fbioe.2023.1108952
8、CRISPR-cas technology: A key approach for SARS-CoV-2 detection
Author: Fang, Lijuan; Yang, Lusen; Han, Mingyue; Xu, Huimei; Ding, Wenshuai; Dong, Xuejun

Journal: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. 2023; Vol. 11, Issue , pp. -. DOI: 10.3389/fbioe.2023.1158672

投稿常見問題

免责声明

本站合法持有《出版物经营许可证》，仅销售经国家新闻出版署批准的合法期刊，不是任何杂志官网，不涉及出版事务。本站仅提供有限咨询服务，需要用户自己向出版商投稿且没有绿色通道，是否录用一切以出版商通知为准。提及的第三方名称或商标，其知识产权均属于相应的出版商或期刊，本站与上述机构无从属关系，所有引用均出于解释服务内容的考量，符合商标法规范。本页信息均由法务团队进行把关，若期刊信息有任何问题，请联系在线客服，我们会认真核实处理。若用户需要出版服务，请联系出版商通訊方式：AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015。